No Data
No Data
China Resources Land's Gross Contracted Sales Increase 7% in November
CITIC SEC: The policy framework continues in 2025, with increased policy support helping the Real Estate sector stabilize and rebound.
In the medium to long term, China's real estate market has a broad base of genuine demand, and the supply-side reform has basically been completed, providing a promising development prospect for high-quality Real Estate Development companies.
[Hong Kong Stock Connect] CHINA RES LAND (01109) fell 3.13% in early trading, with the cumulative contract sales amount for the first 11 months decreasing by 19.9% year-on-year.
Jingwu Finance News | CHINA RES LAND (01109) faced setbacks at the beginning of trading, as of the time of reporting, it fell by 3.13%, trading at HKD 23.25, with a transaction volume of HKD 97.69 million. On the news front, the company announced that for the month ending November 30, 2024, the company and its subsidiaries achieved a total contract sales amount of approximately RMB 25.8 billion and a total contract sales area of approximately 1.203 million square meters, representing year-on-year growth of 6.9% and 11.1%, respectively. The cumulative contract sales amount for the first eleven months of 2024 is approximately RMB 229.1 billion, with a total contract sales area of approximately 10.031 million square meters.
Announcement Highlights | Air China Limited has completed the issuance of over 0.85 billion A-shares to AVIC Group; CHINA RES LAND's sales in November increased by nearly 7% year-on-year.
In the first 11 months, SINO-OCEAN GP's cumulative contracted sales amounted to approximately 30.6 billion yuan, with 3.73 billion yuan in contract sales for November; CHINA RES LAND's total contract sales amount for November was approximately 25.8 billion yuan, representing a year-on-year increase of 6.9%.
In November, CHINA RES LAND's total contract sales amounted to approximately 25.8 billion yuan, a year-on-year increase of 6.9%.
CHINA RES LAND (01109) announced that for the month ending November 30, 2024, the group achieved a total contracted sales amount of approximately 25.8 billion yuan, with a total contracted sales area of approximately 1.203 million square meters, reflecting year-on-year increases of 6.9% and 11.1% respectively. From January to November 2024, the cumulative contracted sales amount was approximately 229.1 billion yuan, with a total contracted sales area of approximately 10.031 million square meters, representing year-on-year decreases of 19.9% and 16.8%. In November 2024, the group's recurring revenue was about 4.09 billion yuan, marking a year-on-year increase of 11.7%.
Hong Kong Stock Announcement Gold Digging | The small vegetable garden starts accepting subscriptions today. The People's Insurance's premium income increased by 5.5% in the first 11 months.
GRANDPHARMA (00512) Global innovative intravascular dual-mode imaging system NOVASYNC has been approved by the Drug Administration for market launch in China.
104556909 : Ok
QiamTrader : nice
103677010 : noted
Ahmad Fiqri :